Flavonols in action: Targeting oxidative stress and neuroinflammation in major depressive disorder
Major depressive disorder is one of the most common mental illnesses that highly impairs
quality of life. Pharmacological interventions are mainly focused on altered monoamine …
quality of life. Pharmacological interventions are mainly focused on altered monoamine …
Clinical correlates and thyroid hormones of metabolic syndrome in first-episode and drug-naïve major depressive disorder outpatients with and without hyperglycemia …
S Zheng, Z Wang, L Yang, X Zhang - BMC psychiatry, 2023 - Springer
Hyperglycemia and metabolic syndrome (MetS) are common in patients with major
depressive disorder (MDD). This study aimed to explore the prevalence and clinical factors …
depressive disorder (MDD). This study aimed to explore the prevalence and clinical factors …
Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders
Y Li, L Wang, J Huang, P Zhang, Y Zhou, J Tong… - Frontiers in …, 2024 - frontiersin.org
Background Many studies showed disrupted tryptophan metabolism in patients with affective
disorders. The aims of this study were to explore the differences in the metabolites of …
disorders. The aims of this study were to explore the differences in the metabolites of …
[HTML][HTML] Increased Parenchymal Macrophages are associated with decreased Tyrosine Hydroxylase mRNA levels in the Substantia Nigra of people with …
Increased activation of inflammatory macrophages and altered expression of dopamine
markers are found in the midbrains of people with schizophrenia (SZ). The relationship of …
markers are found in the midbrains of people with schizophrenia (SZ). The relationship of …